IL130249A0 - Meiosis regulating compounds - Google Patents

Meiosis regulating compounds

Info

Publication number
IL130249A0
IL130249A0 IL13024997A IL13024997A IL130249A0 IL 130249 A0 IL130249 A0 IL 130249A0 IL 13024997 A IL13024997 A IL 13024997A IL 13024997 A IL13024997 A IL 13024997A IL 130249 A0 IL130249 A0 IL 130249A0
Authority
IL
Israel
Prior art keywords
compounds
regulating compounds
meiosis
useful
meiosis regulating
Prior art date
Application number
IL13024997A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL130249A0 publication Critical patent/IL130249A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Induction Heating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
IL13024997A 1996-12-20 1997-12-19 Meiosis regulating compounds IL130249A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK147896 1996-12-20
US4148897P 1997-02-11 1997-02-11
PCT/DK1997/000584 WO1998028323A1 (en) 1996-12-20 1997-12-19 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
IL130249A0 true IL130249A0 (en) 2000-06-01

Family

ID=26065809

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13024997A IL130249A0 (en) 1996-12-20 1997-12-19 Meiosis regulating compounds

Country Status (12)

Country Link
US (3) US6486145B2 (de)
EP (1) EP0946584B1 (de)
JP (1) JP2001506656A (de)
KR (1) KR20000069616A (de)
AT (1) ATE238339T1 (de)
AU (1) AU746878B2 (de)
CA (1) CA2275683A1 (de)
DE (1) DE69721304T2 (de)
HU (1) HUP9904616A3 (de)
IL (1) IL130249A0 (de)
NO (1) NO313144B1 (de)
WO (1) WO1998028323A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030004148A1 (en) * 1994-06-23 2003-01-02 Byskov Anne G. Regulation of meiosis
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
DE69913513T2 (de) * 1998-05-13 2004-09-30 Novo Nordisk A/S Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
DE69903346T2 (de) * 1998-12-11 2003-01-30 Akzo Nobel N.V., Arnheim/Arnhem 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
CZ20012866A3 (cs) * 1999-02-10 2002-01-16 Schering Aktiengesellschaft Nenasycené cholestanové deriváty, farmaceutické kompozice obsahující tyto deriváty a pouľití těchto derivátů pro přípravu léčiv regulujících meiozu
EP1156821B1 (de) * 1999-02-24 2007-05-02 Novo Nordisk A/S Behandlung von unfruchtbarkeit
CN1353617A (zh) * 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
JP2002538123A (ja) * 1999-03-02 2002-11-12 アクゾ・ノベル・エヌ・ベー （アンドロスト−５−エン−１７β−イル）アルキルスルホキシドおよびスルホンならびに受胎能の調節のためのその使用
JP2002539134A (ja) * 1999-03-09 2002-11-19 アクゾ・ノベル・エヌ・ベー 減数分裂の阻害のための２２ｒ−ヒドロキシコレスタ−８，１４−ジエン誘導体
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
DE60023324T2 (de) * 1999-09-16 2006-07-20 Novo Nordisk A/S Zusammensetzung zur in-vitro befruchtung
EP1127890A1 (de) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid Derivate mit einem an Ring A des Steroidgerüstes kondensierten Ring zur Regulierung der Meiose
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
EP1272618A2 (de) * 2000-04-06 2003-01-08 Novo Nordisk A/S Synchronisation vom cytoplasmatischen und nuklearen reifen von oocyten in-vitro
US6988613B2 (en) 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
DE60225117T2 (de) * 2001-02-06 2009-02-26 Novo Nordisk A/S Behältnis mit niedrigem sauerstoffgehalt, das ff-mas enthält
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US8969543B2 (en) * 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US20080312673A1 (en) * 2007-06-05 2008-12-18 Viswanathan Raju R Method and apparatus for CTO crossing
US9447139B2 (en) 2010-04-09 2016-09-20 The Research Foundation Of State University Of New York Ship inhibitors and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
DE1183079B (de) 1961-11-27 1964-12-10 Vismara Francesco Spa Verfahren zur Herstellung von gesaettigten 4-Hydroxy-3-keto-5alpha-steroiden
CH470374A (de) 1965-09-24 1969-03-31 Hoffmann La Roche Verfahren zur Herstellung von Steroiden
DE1593492A1 (de) 1966-01-29 1970-07-16 Schering Ag 6-Ketosteroide aus 20-Formyl-6-keto-Steroide
IL38540A0 (en) 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
ZA725157B (en) 1971-07-29 1973-04-25 Dauten Sa New steroid of insecticide action and process for its production
US4670190A (en) 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
FR2219943B1 (de) 1973-03-02 1976-04-30 Eisai Co Ltd
IL41923A (en) 1973-04-01 1978-08-31 Yeda Res & Dev Preparation of hydroxylated derivatives of cholestanol and some such compounds
US3931403A (en) 1973-05-25 1976-01-06 Intellectual Property Development Corporation Antimicrobial compositions
US3887545A (en) 1973-11-12 1975-06-03 Hoffmann La Roche Synthesis of 1{60 -hydroxylated cholesterol derivatives
JPS5119752A (en) 1974-08-07 1976-02-17 Masayuki Ishikawa 1 arufua* 2 arufuaa jihidorokishikorekarushifuerooruno seiho
IL45897A (en) 1974-10-22 1978-12-17 Yeda Res & Dev Process for the preparation of 1 hydroxy-provitamin d3
JPS6039278B2 (ja) 1977-05-23 1985-09-05 中外製薬株式会社 ステロイド誘導体
EP0015122B1 (de) 1979-02-15 1983-09-14 Teijin Limited 25-Hydroxy-24-oxo-cholestan-Derivate und deren Herstellung
US4230626A (en) 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4254045A (en) 1980-04-21 1981-03-03 Wisconsin Alumni Research Foundation 1α-Hydroxy-2β-fluorocholecalciferol
GB2089810B (en) 1980-09-22 1984-09-19 Wisconsin Alumni Res Found 23,25-dihydroxyvitamin d3 precursors
ATE15050T1 (de) 1981-04-29 1985-09-15 Hoffmann La Roche Verfahren zur herstellung von cholesterinderivaten und zwischenprodukte dafuer.
US4329295A (en) 1981-06-29 1982-05-11 G. D. Searle & Co. 24-Cyclopropylcholene-3β, 22-diols and esters thereof
US4348328A (en) 1981-11-09 1982-09-07 G.D. Searle & Co. 25-Substituted-5α-cholestane-3β,22S-diol
US4871727A (en) 1987-12-21 1989-10-03 Merck & Co, Inc. Anti-inflammatory and antidegenerative compounds isolated from L-681,512
JPH0749435B2 (ja) 1988-07-04 1995-05-31 帝人株式会社 １α，３β，２４−トリヒドロキシ−△▲上５▼−ステロイド類の製造方法
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
PL322106A1 (en) * 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation

Also Published As

Publication number Publication date
EP0946584B1 (de) 2003-04-23
NO993009L (no) 1999-08-19
WO1998028323A1 (en) 1998-07-02
HUP9904616A2 (hu) 2000-06-28
NO313144B1 (no) 2002-08-19
AU7878998A (en) 1998-07-17
CA2275683A1 (en) 1998-07-02
NO993009D0 (no) 1999-06-18
US6759400B2 (en) 2004-07-06
AU746878B2 (en) 2002-05-02
US20010005757A1 (en) 2001-06-28
JP2001506656A (ja) 2001-05-22
ATE238339T1 (de) 2003-05-15
US20050004382A1 (en) 2005-01-06
HUP9904616A3 (en) 2001-02-28
EP0946584A1 (de) 1999-10-06
US20030032824A1 (en) 2003-02-13
DE69721304D1 (de) 2003-05-28
KR20000069616A (ko) 2000-11-25
DE69721304T2 (de) 2004-03-04
US6486145B2 (en) 2002-11-26

Similar Documents

Publication Publication Date Title
AU7878998A (en) Meiosis regulating compounds
MX9700174A (es) Derivados de esterol usados para la regulacion de la meiosis.
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
MD1616F2 (en) Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
NZ336042A (en) Farnesyl transferase inhibitors
SE9302431D0 (sv) Use of indenoindole compounds
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
AU2634597A (en) Compounds with growth hormone releasing properties
MY143570A (en) Compounds useful for inhibition of farnesyl protein transferase
NO20005667L (no) Meioseregulerende forbindelser
TR199901386T2 (en) �midazopiridazinler.
TR199901275T2 (xx) Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler.
IN187760B (de)
AU2566101A (en) Compounds and methods for the treatment of pain
MX9800123A (es) Compuestos que regulan la meiosis.
DK0809627T3 (da) Hidtil ukendte borneolderivater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DE60023034D1 (en) Cd45 hemmer
DE59202744D1 (de) 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung.
BR9713762A (pt) Composto, uso dos mesmos, e, processo para regular a meiose em uma célula germinativa de mamìfero.
DE69532959D1 (de) D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung
MX9706565A (es) Estimulacion de meiosis.
EP1135114A4 (de) Methode zur reduzierung von durch freie radikale induzierte schäden